1. 107 Effects of IL-2 and IL-15 on the proliferative and antitumor capacities of allogeneic CD20 CAR-engineered γδ T cells in a 3D B cell lymphoma spheroid assay. (9th November 2020) Authors: Bai, Lu; Nishimoto, Kevin; Turkoz, Mustafa; Herrman, Marissa; Romero, Jason; Satpayev, Daulet; Abbot, Stewart; Hayes, Sandra; Brodey, Mary Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 107 Effects of IL-2 and IL-15 on the proliferative and antitumor capacities of allogeneic CD20 CAR-engineered γδ T cells in a 3D B cell lymphoma spheroid assay. (9th November 2020) Authors: Bai, Lu; Nishimoto, Kevin; Turkoz, Mustafa; Herrman, Marissa; Romero, Jason; Satpayev, Daulet; Abbot, Stewart; Hayes, Sandra; Brodey, Mary Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models. Issue 2 (2nd February 2022) Authors: Nishimoto, Kevin P; Barca, Taylor; Azameera, Aruna; Makkouk, Amani; Romero, Jason M; Bai, Lu; Brodey, Mary M; Kennedy‐Wilde, Jackie; Shao, Hui; Papaioannou, Stephanie; Doan, Amy; Masri, Cynthia; Hoang, Ngoc T; Tessman, Hayden; Ramanathan, Vidhya Dhevi; Giner‐Rubio, Ana; Delfino, Frank; Sharma, Kr... Journal: Clinical & translational immunology Issue: Volume 11:Issue 2(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗